🔎 Trials Near Me

Home › Atrial Fibrillation › Alabama › Birmingham

Atrial Fibrillation clinical trials in Birmingham, AL

7 studies for Atrial Fibrillation are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

Recruiting
  • Grandview Medical Center, Birmingham
Ages 18 to 80 · All sexes · Updated Sep 25, 2026 · NCT07527299

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

RecruitingObservational study
  • University of Alabama at Birmingham, Birmingham
  • Grandview Medical Center, Birmingham
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT04088071

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

Recruiting
  • University of Alabama at Birmingham (UAB) Hospital, Birmingham
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07298473

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

Recruiting
  • Grandview, Birmingham
Ages 18 to 80 · All sexes · Updated Jul 15, 2026 · NCT06784466

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

RecruitingPhase 3
  • Anthos Investigative Site 1040, Birmingham
  • Anthos Investigational site 9939, Birmingham
  • Anthos Investigative Site 9947, Birmingham
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT05712200

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

RecruitingPhase 3
  • University of Alabama Hospital, Birmingham
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

RecruitingObservational study
  • Arrhythmia Institute at Grandview, Birmingham
Ages 18 and older · All sexes · Updated Oct 31, 2025 · NCT06324201

About Atrial Fibrillation

Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.

More about Atrial Fibrillation on MedlinePlus

Atrial Fibrillation trials in other cities

Other studies in Birmingham

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.